Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

not at all sure why you would direct your response to me, but:

my ONLY interest in all of this is to have some measured reaction to P2a results, as opposed to wild-eyed optimism($10 billion, etc)

nothing more, nothing less

just consider how weak/flimsy the data really are thus far

and, yet, to expect a new data set for 300/400 mg doses:

maybe better, maybe worse

I believe the future here clearly resides with Brilacidin franchise and will be thrilled if P is a winner too